Johnson & Johnson Reports 2025 Q3 Sales Growth, Raises Full-Year Outlook
Published on October 15, 2025
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) yesterday announced its third quarter 2025 financial results. The company reported year-over-year Q3 sales growth of 6.8 percent to $24.0 billion, with operational growth of 5.4 percent and adjusted operational growth of 4.4 percent.